Switching plan: what timing is safest if changing therapies
We then performed metabolomic, lipidomic, and proteomic profiling in parallel on pooled samples of serum and of vHipp, NAc, and mPFC of susceptible, resilient, and undefeated control mice to capture the full spectrum of molecular changes in blood and brain that differentiate these populations (Fig
J Biol Chem 272:2303123036 El Idrissi A (2019) Taurine regulation of neuroendocrine function
Early data from amycretin showed up to 13.1% weight loss in just 36 weeks of a phase 1/2 trial, with the weight loss curve still descending steeply
GSTP1 is responsible for metabolism of alkylating agents, topoisomerase inhibitors, antimetabolites, or tubulin inhibitors used in treatment of cancer